PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

204 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Luecken, M. et al.: The discovAIR project: A roadmap towards the Human Lung Cell Atlas. Eur. Respir. J. 59:2102057 (2022)
22.
Maison, N. et al.: T-high asthma phenotypes across life span. Eur. Respir. J. 60:2102288 (2022)
23.
Schniering, J. ; Maciukiewicz, M.* ; Tanadini-Lang, S.* & Maurer, B.*: Reply to: The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis. Eur. Respir. J. 59:2200303 (2022)
24.
Van Eeckhoutte, H.P.* et al.: RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. Eur. Respir. J. 61:2201506 (2022)
25.
van Meel, E.R.* et al.: Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: A meta-analysis of 150 000 European children. Eur. Respir. J. 60:2102395 (2022)
26.
Hoeper, M.M.* et al.: COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension. Eur. Respir. J. 60:2102311 (2021)
27.
Kammerl, I.E. et al.: Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients - implications for therapy. Eur. Respir. J. 59:2101798 (2021)
28.
Lamort, A.-S. et al.: Prognostic phenotypes of early-stage lung adenocarcinoma. Eur. Respir. J. 60:2101674 (2021)
29.
Schniering, J. et al.: Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis. Eur. Respir. J. 59:2004503 (2021)
30.
Schunk, M.* et al.: Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: A pragmatic fast track randomised controlled trial (BreathEase). Eur. Respir. J. 58:2002139 (2021)
31.
Weckmann, M.* et al.: COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. Eur. Respir. J. 58:2003969 (2021)
32.
Behr, J. et al.: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: Long-term results of the INSIGHTS-IPF registry. Eur. Respir. J. 56:1902279 (2020)
33.
Greiffo, F.R. et al.: CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases. Eur. Respir. J. 55:1900460 (2020)
34.
Kaiser, J.C. & Stathopoulos, G.T.: Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks. Eur. Respir. J. 56:2001400 (2020)
35.
Morrone, C. et al.: Cathepsin B promotes collagen biosynthesis driving Bronchiolitis Obliterans Syndrome. Eur. Respir. J. 57, DOI: 10.1183/13993003.01416-2020 (2020)
36.
Bahmer, T.* et al.: miR-122-5p and miR-191-5p are increased in plasma small extracellular vesicles in asthma. Eur. Respir. J. 54 (2019)
37.
Bedard, A.* et al.: Is the association between physical activity and lung function due to reverse causation? Application of exploratory and causal approaches. Eur. Respir. J. 54 (2019)
38.
Behr, J.* et al.: Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: Long-term results of the INSIGHTS-IPF registry. Eur. Respir. J. 54 (2019)
39.
Chen, J. et al.: LSC-2019-Effect of cigarette smoke on immunoproteasome function during virus infection. Eur. Respir. J. 54 (2019)
40.
Fuertes, E.* et al.: Lung function up to adolescence and residential greenspace. Eur. Respir. J. 54 (2019)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮